To the best of our knowledge, our study is the first one comprehensively analysing the impact of frequently investigated common inherited variants of genes for PD-1, PD-L1 and TIM-3 in European NSCLC patients. This evidence concerns the gene HAVCR2 and non-small cell lung carcinoma.